0001437749-22-015660.txt : 20220622 0001437749-22-015660.hdr.sgml : 20220622 20220622190317 ACCESSION NUMBER: 0001437749-22-015660 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220620 FILED AS OF DATE: 20220622 DATE AS OF CHANGE: 20220622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CANNON MICHAEL D CENTRAL INDEX KEY: 0001203602 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 221033236 MAIL ADDRESS: STREET 1: C/O SICOR INC STREET 2: 19 HUGHES CITY: IRVINE STATE: CA ZIP: 92618-1902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 4 1 rdgdoc.xml FORM 4 X0306 4 2022-06-20 0001659617 Moleculin Biotech, Inc. MBRX 0001203602 CANNON MICHAEL D C/O MOLECULIN BIOTECH, INC. 5300 MEMORIAL DR., SUITE 950 HOUSTON TX 77007 1 Stock option (right to buy) 1.49 2022-06-20 4 A 0 23333 A 2032-06-20 Common Stock 23333 50001 D Stock option (right to buy) 1.49 2022-06-20 4 A 0 15000 A 2032-06-20 Common Stock 15000 65001 D The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. The options set forth in this table vest on the earlier of one year from the date of the Company's 2022 annual meeting of stockholders or on the date of the next annual meeting of stockholders, subject the grantee's continued service on the Company's Board of Directors on each vesting date. The options were issued in connection with the reporting person's Board of Director service to the Company. /s/ Jonathan Foster by Power of Attorney 2022-06-22 EX-24 2 cannon_poa.htm mbrx20220621e_corresp.htm

Exhibit 24

 

POWER OF ATTORNEY

 

The undersigned, as a person who are required to file with the Securities Exchange Commission (“SEC”) public reports disclosing their holdings of, and transactions in, the equity securities of Moleculin Biotech, Inc. (the “Company”) under Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the “1934 Act”), hereby constitutes and appoints each of Walter V. Klemp and Jonathan P. Foster as the undersigned’s true and lawful attorney-in-fact to:

 

 

1.

Complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in her discretion determine to be required or advisable pursuant to Section 16 of the 1934 Act, as a consequence of the undersigned’s ownership, acquisition or disposition of any equity securities of the Company; and

 

 

2.

Do all acts necessary in order to file such forms with the SEC, any securities exchange or national association, the Company and such other person or agency as the attorney-in-fact shall deem appropriate.

 

Each of said attorneys-in-fact shall individually have the authority to act in accordance with this Power of Attorney. The undersigned hereby ratifies and confirms all that each of said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that each of the foregoing attorneys­in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the 1934 Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and any one of the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 21st day of June 2022.

 

 

Signature:          /s/ Michael D. Cannon         
                  Michael D. Cannon